AIM2 and hepatocellular carcinoma: In an in vitro study, knocking down AIM2 in HCC cells enhanced cell migration, the formation of cell pseudopodium, wound healing, and led to the activation of epithelial–mesenchymal transition (EMT) tumor metastasis, whereas the reintroduction of AIM2 attenuated these effects [50].